Health Canada Issues Recall of Auro Pharma`s Losartan 25/50/100mg tablets
Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs
Health Canada Issue Recalls of Auro Pharma's Losartan
The FDA has had a long and troubled history with compounding pharmacies, which create tailor-made versions of doctor-prescribed drugs. Advocates say the FDA's crackdown on pharmacy quality has been draconian, at times, but sometimes those facilities bring it on themselves.
Auro Pharmacies, Inc., dba Central Drugs Compounding Pharmacy Receives FDA Warning Letter
Health Canada Issues Recall of Auro Pharma Auro-Irbesartan HCT Tablet
Enforcement Report - Week of April 17, 2019